Net product sales — Total Revenues
Bristol-Myers Squibb Net product sales — Total Revenues decreased by 0.5% to $11.85B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.2%, from $11.48B to $11.85B. Over 3 years (FY 2021 to FY 2024), Net product sales — Total Revenues shows relatively stable performance with a 1.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong market adoption and successful commercialization of the drug portfolio, while a decrease may signal competitive pressure, patent expirations, or declining demand.
Detailed definition
This metric represents the total revenue generated from the sale of pharmaceutical products after accounting for returns...
Peer comparison
This is a standard top-line revenue metric across the pharmaceutical industry, comparable to 'Net Sales' reported by peers like Merck or Pfizer.
bmy_segment_net_product_sales_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.26B | $11.26B | $11.26B | $11.31B | $11.49B | $10.81B | $11.07B | $11.05B | $10.92B | $10.65B | $11.17B | $11.56B | $11.93B | $11.48B | $11.81B | $10.89B | $11.91B | $11.85B |
| QoQ Change | — | +0.0% | +0.0% | +0.4% | +1.6% | -5.9% | +2.3% | -0.2% | -1.2% | -2.5% | +4.9% | +3.5% | +3.2% | -3.7% | +2.9% | -7.8% | +9.4% | -0.5% |
| YoY Change | — | — | — | — | +2.0% | -4.0% | -1.8% | -2.3% | -4.9% | -1.6% | +0.9% | +4.6% | +9.2% | +7.9% | +5.8% | -5.8% | -0.1% | +3.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's net product sales — total revenues?
- Bristol-Myers Squibb (BMY) reported net product sales — total revenues of $11.85B in Q3 2025.
- How has Bristol-Myers Squibb's net product sales — total revenues changed year-over-year?
- Bristol-Myers Squibb's net product sales — total revenues increased by 3.2% year-over-year, from $11.48B to $11.85B.
- What is the long-term trend for Bristol-Myers Squibb's net product sales — total revenues?
- Over 3 years (2021 to 2024), Bristol-Myers Squibb's net product sales — total revenues has grown at a 1.3% compound annual growth rate (CAGR), from $45.06B to $46.78B.
- What does net product sales — total revenues mean?
- The total revenue earned from selling pharmaceutical products after accounting for sales adjustments.